Clinical Use and Patentability of Cord Blood
Makaleler > Tam Makale · 2018
Yazarlar: Türker Cavusoğlu, Kubilay Doğan KILIÇ, Gurkan Yigittürk, Canberk Tomruk, Mehmet Turgut, Yiğit UYANIKGİL
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, SCI Expanded İndekslerine Giren Dergi, Uluslararası, Scopus, 2018, cilt 11, ss 13-21
DOI: 10.2174/1872214812666180314121241
Özet
BACKGROUND: The blood in the umbilical cord that provides the connection between mother and fetus during pregnancy is called cord blood. The blood of umbilical cord which is usually got rid of following birth, is a very rich stem cell source. OBJECTIVE: Cord blood collection gives no harm to the mother and baby. Besides, its allogeneic and autologous usage, the most important disadvantage is that the number of cells is insufficient in adults. CONCLUSION: Today, it is predominantly used for therapeutic purposes for many diseases. The aim of this review is giving a detailed information about groups of stem cells in cord blood and determining the point of clinical use.